An AI drug discovery company designing therapeutic antibodies computationally, with programs targeting oncology and infectious disease.
Silico Biosciences / Tuple
Released October 16, 2025
Suite of large language models fine-tuned with LoRA to generate antigen-targeted antibody Fv sequences from an antigen and its epitope.